181 related articles for article (PubMed ID: 6703684)
41. Synthesis and antiviral activity of metabolites of rimantadine.
Manchand PS; Cerruti RL; Martin JA; Hill CH; Merrett JH; Keech E; Belshe RB; Connell EV; Sim IS
J Med Chem; 1990 Jul; 33(7):1992-5. PubMed ID: 2362279
[TBL] [Abstract][Full Text] [Related]
42. Effects of 1-beta-D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis.
Oxford JS
J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):71-6. PubMed ID: 1239442
[No Abstract] [Full Text] [Related]
43. Combined action of ribovirin and rimantadine in experimental myxovirus infection.
Galegov GA; Pushkarskaya NL; Obrosova-Serova NP; Zhdanov VM
Experientia; 1977 Jul; 33(7):905-6. PubMed ID: 891769
[No Abstract] [Full Text] [Related]
44. [Parent and recombinant influenza virus A strains differing in the degree of remantadine sensitivity].
Vodeĭko GM; Zazimko LA; Farashian VR; Zhdanov VM
Vopr Virusol; 1982; 27(2):214-8. PubMed ID: 7090347
[TBL] [Abstract][Full Text] [Related]
45. Combined antiinfluenza activity of a plant preparation SHS-174 and amantadine derivatives.
Serkedjieva J; Zgorniak-Nowosielska I
Acta Virol; 1993 Aug; 37(4):258-64. PubMed ID: 7905240
[TBL] [Abstract][Full Text] [Related]
46. Activity of selenazofurin against influenza A and B viruses in vitro.
Sidwell RW; Huffman JH; Call EW; Alaghamandan H; Cook PD; Robins RK
Antimicrob Agents Chemother; 1985 Sep; 28(3):375-7. PubMed ID: 4073860
[TBL] [Abstract][Full Text] [Related]
47. Deproteinization of influenza virus in the presence of rimantadine.
Bubovich VI; Ryazantseva GM; Indulen MK
Acta Virol; 1985 Mar; 29(2):104-10. PubMed ID: 2408452
[TBL] [Abstract][Full Text] [Related]
48. Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
Bull World Health Organ; 1985; 63(1):51-6. PubMed ID: 3872736
[TBL] [Abstract][Full Text] [Related]
49. [Effect of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methyl amine) hydrochlorides on formation of influenza A viral proteins].
Galegov GA; Vladyko AS; Linitskaia GL; Shobukhov VM
Vopr Med Khim; 1981; 27(2):251-4. PubMed ID: 7281566
[TBL] [Abstract][Full Text] [Related]
50. [In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005].
L'vov DK; Fediakina IT; Shchelkanov MIu; Prilipov AG; Deriabin PG; Galegov GA
Vopr Virusol; 2006; 51(2):20-2. PubMed ID: 16756173
[TBL] [Abstract][Full Text] [Related]
51. [Change in the influenza virus upon multiplication in the presence of high concentrations of remantadine].
Karako NI; Boreko EI; Kirillov VA; Votiakov VI
Vopr Virusol; 1989; 34(1):43-6. PubMed ID: 2728406
[TBL] [Abstract][Full Text] [Related]
52. [Bis-(N,N'-uracil-1-yl)-selenoxomethane: an inhibitor of the influenza virus].
Lazymova ZA; Asadullaev TA; Mamedov ESh; Akhverdieva RIa
Vopr Virusol; 1988; 33(2):163-5. PubMed ID: 3414065
[TBL] [Abstract][Full Text] [Related]
53. Susceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 1990.
Valette M; Allard JP; Aymard M; Millet V
Antimicrob Agents Chemother; 1993 Oct; 37(10):2239-40. PubMed ID: 8257151
[TBL] [Abstract][Full Text] [Related]
54. [Structure and antiviral activity of adamantane-containing polymer preparation].
Kozeletskaia KN; Stotskaia LL; Serbin AV; Munshi K; Sominina AA; Kiselev OI
Vopr Virusol; 2003; 48(5):19-26. PubMed ID: 14598476
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the effect of rimantadine on intracellular distribution and transport into the nuclei of infected cells of the parent influenza virus genome.
Kozeletskaya KN; Yukhnova LG; Golubev DB
Acta Virol; 1984 Nov; 28(6):464-72. PubMed ID: 6152124
[TBL] [Abstract][Full Text] [Related]
56. [Interaction of rimantadine with the lipid membrane of influenza virus variants sensitive to the drug].
Kharitonenkov IG; Ginzburg VP; Klimov AI; Tikhonov AN
Vopr Virusol; 1982; 27(5):52-4. PubMed ID: 7147902
[No Abstract] [Full Text] [Related]
57. Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
Webster RG; Kawaoka Y; Bean WJ
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():157-64. PubMed ID: 3793657
[TBL] [Abstract][Full Text] [Related]
58. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.
Zvonarjev AY; Ghendon YZ
J Virol; 1980 Feb; 33(2):583-6. PubMed ID: 6893343
[TBL] [Abstract][Full Text] [Related]
59. [Inhibitory action of adenylyl-[3'--5']-ribavirin on the RNA polymerase activity of influenza A viruses].
Pravdina NF; Shobukhov VM; Galegov GA
Dokl Akad Nauk SSSR; 1984; 274(4):975-8. PubMed ID: 6734413
[No Abstract] [Full Text] [Related]
60. [Tissue reaction and influenza virus infectiousness during multiplication in tissue culture in the presence of remantadine].
Votiakov VI; Boreko EI; Zaporozhets LK
Vopr Virusol; 1984; 29(4):468-73. PubMed ID: 6495707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
